Clinical Trial

Effectiveness of 3D Bone Matrix in Cranioplasty

Study acronym: OSTEOPRINTCR
Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2025 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this clinical trial is to evaluate the effectiveness of a 3D bone scaffold in relation to a scaffold formed by PCL + β-TCP (polycaprolactone and beta-tricalcium phosphate), compared to the use of PMMA (polymethyl methacrylate) acrylic cement for bone regeneration in patients undergoing cranioplasty in the city of Valdivia, Chile, between the years 2024-2025. The main beneficiaries will be patients, users of the public or private health system, who require bone regeneration. The intermediate beneficiaries are the health team: doctors specialized in surgery and orthopedics, dedicated in their professional work to bone reconstruction and regeneration.
Trial Details
NCT Number NCT06792864
Lead Sponsor Universidad Austral de Chile
Conditions Cranioplasty, Craniotomy, Craniotomy Clipping, Craniotomy Surgery, Craniocerebral Trauma, Craniocerebral Injuries
Enrollment 8 participants
Start Date 2024-07-01
Primary Completion 2025-03-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-27